Member Info for AB124

DeAar
You're surprised that Vulpes haven't bought some shares (to support the SP presumably as they did before)?
I'm not at all surprised.
The previous situations in which they very publicly bought shares was in a completely different Scancell market. I did mention this some days ago.
Someone once told me that there's no point in standing alone on the bridge (Trying to turn the tide) when several chapters of Hell's Angels are coming at you full throttle the other way.
Very sound advice that Vulpes seem to have understood.
I'm sure (well I hope) there'll be some evidence of their involvement at some point but when that is only they know. Maybe they've already been in but haven't seen a DD RNS yet.
AIMO

Very short term it will be interesting to see where we close today.
13.25 is a support that would be good to hold, so fingers crossed.
Hopefully any new investment at these levels will seem to be good IDC but we need some positive Data/Revelations from the company I think.
AIMO

Chester,
I see what you say and don't really disagree with any of it, but in all honesty the Burble post was helpful to me in that for some reason I thought that the fact we'd got things going before was a positive. Having digested why the NHS might in some centres prefer to go with bigger, poerhaps in some people's eyes more "business" friendly propositions, and given the singular lack of recent tangible positives from the company I setlled back into my own little world and decided things were going to take longer than I'd thought/hoped they might.
Once I got over the initial self inflicted disappointment I came to the conclusion it was the place I wanted to be; not expecting more than Scancell had ever managed to do in the past. That being to exceed expectations of the patient LTH in terms of trial commencements both on time and Data provision.
I'm sure my mindset in this case has helped me past the disappointments that we've already met along the way.
So here's to Scancell amazing me by exceeding my expectations!
Fingers Crossed...
AIMO

Hi Chester,
I think it was Burble (apologies if I'm wrong) was saying some time back that the size and clout of a company wanting to get trials going is significant in terms of where it sits in the "pile". The bigger and more influential the Company (and size of trial) the more attractive it is to any given centre to whom an approach is made. Seems that economies of scale come into it.
At least, that's how I undstood it and so I've become more accepting that Data might well be further down the road than the more optimistic suggestions we've been used to thinkng about.
It might be that other LTH have begun to think in that way, which would add to the general market malaise caused by the more universal worries that are battering the market (as well as Scancell shares) generally ATM.
Maybe a trial announcement will come sooner than expected but I'm not overly optimistic.
I take that stance because I'd rather be surprised than disappointed TBH.
AIMO

That's why I asked.. So you say nobody's responsible? Really?
Look, don't worry, it just says to me there's a bit if a gap in the setup. Not a great deal of support for the world beating science?
Anyway I suppose it will al come together in due course.
AIMO
Have a good weekend all.

I've been reading people criticising Scancell's PR here this afternoon. I have not raised it I have read it.
If scancell's PR is poor and not up to scratch, who in the company is ultimately responsible?

Cleanerworld,
Buffett cetainly has claim to be quoted, but I believe his portfolio is not comprised solely of Baby bios.
There's a place for speculative investments in any well diversified portfolio but many these days have but one shareholding to which they might have become attached.
Scancell has been a particularly tradeable share over the years in that it has seen wild price gyrations which almost beg for "top slicing" or even at one stage complete disinvestment.
I believe to criticise anyone for seeing that is wrong. Ownership of Scancell for ten years (a la Buffett) has (in some self admitted cases) simply brought the non proactive owners back to break even.
I am of an age where equity share investment was seen as a five year cycle but that applies not to start up companies but those which are producing something which can be sold and which will produce revenue for shareholders.
Scancell is producing something but in ten years has singularly failed to produce shareholder beneficial revenue, so I believe it is not quite the same sort of investment which Buffett was referring to. If I am wrong and it is, then it's stretching a point to suggest that a Bio start up is a directly comparable investment to a Buffett. However if you argue that it is, then the company has failed the ten year test for many LTH here.
As you say it's good to exchange views without acrimony.
Hope you agree that this is the case here. Great to discuss.
ATB

Cleanerworld,
Why naive?
You ask a question and people respond. At least you're prepared to listen to all sides of the situation rather than simply pretending that those who don't agree with your own view can't possibly be right.
You are the ultimate arbiter of whether you believe the responses and that's as it should be.
I find it refreshing that you ask and will take your question at face value.
Again, thanks for taking the time to correspond.
ATB

Cleanerworld,
What a refreshing attitude you have!
ATB

Cleanerworld
I think Vulpes won't (rather than can't ) Buy ATM.
Sorry not to be a believer in the idea that their hands are bound because of inside information, but that's what makes both sides of a market.
I really believe at these levels we really need Data to get back on track.
Having said that we'll probably get a DD RNS this afternoon, but that's the risk you take when being proactive in portfolio management. :-)
Hope you don't mind me commenting.
AIMO

Dalestar
Can't disagree fundamentally with any if your comments apart from one.
That is as we do have RMs involvement I'm disappointed that we are where we are and I believe that this is a major part of the frustration inthat the company has ( and has had) the support for more than a year) and still the forward momentum appears stalled. The RNS appointing RG as a temporary stop gap suggests that issues have now been identified and so it appears the "jitters" have continued during a most unfortunate time in the markets' buffeting by matters economical political. Sadly it doesn't help knowing why the weakness has occurred it simply has and some investors/traders have voted with their feet. Amazingly for the present I suspect that some who have taken that route will be happy with their decision. Hopefully they will have to reconsider their situation sooner rather than later.
AIMO

Crumbs,
From my point of view a great deal was evident from the last two years charts.
Maybe my imagination/deductions are not based on obvious and identifiable differences.
I've tried to keep an open mind on the direction of the company's SO and the husbandry of the IP
I think today's exchanges have helped me begin to understand how differently people see Scancell. I'm prepared to try and think the unthinkable. Many seem to think that it's wrong to question the perceived knowledge. I'm not sure that I understood that until now.
That's a shame.
Probably best that I simply leave the question of Scancell to those here who know all about it and know what will happen to the SP from day to day. It is disappointing that many here are unable to tolerate any ideas that don't stick rigidly to their own. There is also little charity from some here who seem to expect it for themselves but prefer not to give it unless it suits.
I think a great deal of useful information is lost when tolerance of alternative views simply isn't there.
Thanks for your input this evening. At least I believe we respect each others views.
AIMO

Crumbs thanks for your fuller response. Appreciated.
I think one of the benefits of incorporating (not relying exclusively on) TA in the armoury of analytical tools for investment is that a chart is a picture from which trading patterns and ranges can be seen rather than merely being a series of random numbers in an investors head.
Obviously there are some who rely exclusively on Charts and that is entirely up to them but I wouldn't be comfortable with that.
If people want to mock TA good for them, but it's given me confidence to make large trades in the past which have proved profitable. I'd like to say I've never made a loss but that wouldn't be true. I can say though that I am showing a good annual profit over the last thirty or so years ,(with two or three exceptions) by trading and often simply buying and holding.
I suspect some here will want to argue with that. They can, I won't.
As to your mention of "dark news" if you'd like to elaborate (I don't recall mentioning dark news) if I understand what you mean I'll try and respond.
Otherwise have a look at Scancells chart over the last two years and then look at the patterns for the previous three. Notice anything radically different?
AIMO

Crumbs,
You can do better than that, surely?
I was asked for a comment so I made it.
It was a specific question to which I replied.
I'll certainly think twice about responding in the future.
Enjoy your evening.

A close above 14p means that the major support and so the present base is intact. Should the support be breached th at support becomes resistance and the more closes below that new resistance the greater the work required to climb back to the previous range.
So far so good.
Tomorrow is another day.
How that helps.
AiMO

Well, Scancell shares now offered in good size below the opening bid today.
The close this afternoon is quite important so it will be interesting to see where we actually finish.
AIMO

Crackin,
Retracing the "Jump" I'll not argue with but there's no TA gap on that.
So Insider on bad news?
A deliberate dump to take out stops?
Because scancell are too slow at anything?

I'll add another one
An attempt (so far successful) to engineer the SP down for a Redistribution?

That might make sense if it was felt the lack of commercialisation was not the fault of the science.
So there's my contribution to explain the more than surprising drop in the SP over the last few weeks.
AIMO

Crackin
There was no gap at 13.9 in Feb last, it was filled intraday on next trading day 15th.
If you want an unfilled gap to consider try 26th/27th Aug 20 at 7.5p!
Hopefully that breakout gap will remain unfilled!
If I've missed something apols.
AIMO

Crackin,
Looking at the chart over the last year I know which of your suggestions in your last sentence I subscribe to!
It's not rocket science is it?
I think you'll know what I mean.
AIMO

Hasiba
I see support at 13.3 short/med. I take it your 13.99 is a "sentiment" level rather than mathematical?
Also, what GAP are you talking about? Can't see one. Can you give me the two dates that show it?
Are you no longer short term bullish?